OPA1 and glomerulosclerosis: In a mouse model, the increase of OPA-1, a master regulator of mitochondrial cristae morphology, reduces mitochondrial damage from various causes, including mitochondrial DNA depletion-induced glomerulosclerosis [26] and sorafenib-induced (an anticancer agent) hepatocyte apoptosis [27].